Wellster Healthtech Group
Wellster Healthtech Group operates a multi-brand Direct-to-Patient telemedicine ecosystem in Europe, serving over 2 million patients across men's health, women's health, obesity (GLP-1), hair loss, cannabis, and self-testing via German-licensed physicians.
- Company typePrivate
- Founded2018
- HeadquartersMunich, Germany
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Wellster Healthtech Group does
Wellster Healthtech Group is a Munich-based Direct-to-Patient digital health platform founded in 2018 by Dr. Manuel Nothelfer and Nico Hribernik. The company operates a multi-brand telemedicine ecosystem spanning eight consumer-facing portals — GoSpring (men's health/erectile dysfunction), GoLighter (GLP-1 obesity therapy), MySummer (women's health), MySpring (hair loss), GoEasy (medical cannabis), Easy-Testen (medical self-tests), Apons, and Wellster Medical — covering distinct health verticals under shared medical governance. Underlying technology combines synchronous and asynchronous telemedicine pathways with structured patient triage and a Real-World Evidence data infrastructure built from millions of anonymized treatment data points, with data processed on German servers and clinical oversight provided by a German-based Medical Advisory Board.
The company generates revenue through per-consultation telemedicine fees, prescription medication fulfillment (transaction fees), and OTC product sales, served exclusively via owned digital channels with no third-party distribution. Patient acquisition runs through a multi-channel marketing stack spanning influencer partnerships, SEO/content, HubSpot-driven lifecycle email, and PR in major German business press. Customer base consists entirely of individual consumers; over 2 million patients have used the platform since inception, with published peer-reviewed research (n=11,456) in the International Journal of Sexual Medicine and dermatology providing scientific credibility.
Wellster has raised approximately $100M+ in equity (Series A $40M in 2021, Series B $60M total in 2022) plus a €10M follow-on debt line from Claret Capital Partners in March 2026. FY2025 revenue reached €50M with ~70% year-over-year growth and first-time full-year profitability, making it the first German digital health provider to reach this milestone. In March 2026, Wellster launched GoLighter in Sweden as its first international market.
Wellster Healthtech Group firmographics
Firmographics- Name
- Wellster Healthtech Group
- Legal name
- Wellster Healthtech Group GmbH
- Website
- https://wellsterhealth.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Wellster Healthtech Group operates a multi-brand Direct-to-Patient telemedicine ecosystem in Europe, serving over 2 million patients across men's health, women's health, obesity (GLP-1), hair loss, cannabis, and self-testing via German-licensed physicians.
- Ownership category
- akta.pro rank
Wellster Healthtech Group industry classification
Industry- Product category
- Direct-to-Patient Telemedicine
- NAICS
- Offices of Physicians (6211)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
- akta.pro primary industry
- Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD)
- akta.pro secondary industries
- Endocrinology & Diabetes Telemedicine Platforms (HLALAGAD), Primary Care & General Medicine Virtual Care (HLALAAAA)
Keywords
Where Wellster Healthtech Group is headquartered
LocationHeadquarters
- HQ city
- Munich
- HQ country
- Germany
- HQ region
- Europe
Offices3 records
Markets served
Wellster Healthtech Group business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure, Supply Chain, Others
Revenue model
- Telemedicine Consultations: Direct-to-consumer telemedicine services providing digital medical consultations with German-licensed physicians for various health conditions including erectile dysfunction, obesity, hair loss, and general health concerns
- Prescription Medications: Integrated prescription fulfillment through telemedicine consultations, providing patients with medically supervised access to prescription medications with delivery to patients
- OTC Products: Sale of over-the-counter health products through branded platforms including medical self-tests
Go-to-market motion1 record
Distribution channels1 record
Marketing channels8 records
Wellster Healthtech Group product offering
Product offeringCore offering
Wellster Healthtech Group operates a Direct-to-Patient digital health platform providing asynchronous and synchronous telemedicine consultations with German-licensed physicians, integrated prescription fulfillment, and OTC health products across multiple condition-specific sub-brands (men's health, obesity, women's health, hair loss, medical cannabis, self-testing). The ecosystem has served over 2 million patients and is backed by a German-based Medical Advisory Board, Real-World Evidence data infrastructure, and 'Made in Germany' data processing standards.
Product overview
Wellster Healthtech Group operates a multi-brand digital health ecosystem centered on direct-to-patient telemedicine. The platform integrates a portfolio of seven named sub-brands targeting distinct health conditions: GoLighter (GLP-1-based obesity/weight management), GoSpring (men's health/erectile dysfunction), MySummer (women's health), MySpring (hair loss), GoEasy (medical cannabis), Easy-Testen (medical self-tests), and Apons (specialized health conditions), all supported by the core Wellster Medical telemedicine infrastructure. The ecosystem is unified by shared medical governance (Medical Advisory Board), German-based data processing, and an integrated care model connecting access, treatment, and follow-up. The company also maintains a separate general medical consultation platform under Wellster Medical. The company expanded internationally for the first time in 2026, launching GoLighter in Sweden as a European proof-of-concept market.
Differentiator
Problem solved
Functional benefit
Brands
- GoSpring (gospring.de): Men's health platform addressing erectile dysfunction and related conditions
- GoLighter (golighter.de)
- Summer / MySummer (mysummer.de)
- MySpring (myspring.com)
- Apons (apons.eu)
- WellsterMedical (wellstermedical.com)
- Easy-Testen (easy-testen.de)
- GoEasy (goeasy.de)
Products and services
- GoSpring Men's health platform offering treatment for erectile dysfunction and related conditions via integrated telemedicine. Provides discreet online consultations with German-licensed physicians and prescription delivery for men's health patients.
- GoLighter GLP-1-based digital obesity therapy platform offering medically supervised weight loss treatments. Provides structured digital patient pathways including nutritional advice and ongoing medical supervision for individuals seeking weight management solutions.
- MySummer Women's health platform addressing female sexual health and related concerns through digital healthcare services, providing discreet telemedicine consultations and prescription fulfillment for women's health patients.
- MySpring Hair loss treatment platform providing digital consultations and prescriptions for hair restoration therapies via telemedicine.
- GoEasy Medical cannabis platform providing digital access to cannabis-based treatments via telemedicine consultations with regulatory-compliant prescription fulfillment.
- Easy-Testen Platform providing medical self-tests for various health conditions, enabling patients to conduct diagnostic assessments at home with privacy and convenience.
- Wellster Medical Digital health platform focused on general medical consultations and healthcare services delivered via telemedicine with German-licensed physicians.
- Apons Health platform providing services related to a specific health condition or treatment area within Wellster's digital health ecosystem.
- Wellster Healthtech Digital Health Ecosystem The overarching digital health ecosystem integrating Wellster's portfolio of direct-to-patient health portals. Provides the telemedicine infrastructure, medical advisory oversight, data processing on German servers, and regulatory compliance framework that underpins all sub-brands. Supports both synchronous and asynchronous telemedicine, structured patient triage, and integrated care delivery from consultation through prescription and delivery.
Quantifiable outcome
- 11,456 male patients treated via telemedicine, with study demonstrating improved access to healthcare especially for rural patients and those seeking care outside office hours
- +2 more outcomes
Companies that use Wellster Healthtech Group
Customer profileNamed customers2 records
Segments6 records
Ideal customer profiles4 records
Wellster Healthtech Group technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature3 records
Wellster Healthtech Group partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor, core and strategic.
- NoventiminorCooperation with Noventi, one of Germany's largest healthcare IT companies, expanding distribution and service capabilities for digital health offerings.
- Ludwig-Maximilians-Universität München (LMU Munich)coreResearch cooperation with LMU Munich resulting in the world's first study on erectile dysfunction based on telemedical data. Published peer-reviewed research (11,456 patients) in the International Journal of Sexual Medicine. Partnership demonstrates scientific rigor and provides evidence-based credibility for the telemedicine model.
- Pharma Deutschland (Bundesverband der Pharmazeutischen Industrie)strategicIndustry association membership providing regulatory guidance and industry representation for pharmaceutical and digital health companies in Germany.
Scale indicators10 records
Recent moves9 records
Expansion highlights7 records
Wellster Healthtech Group competitors and assessment
Company assessmentDirect peers
- Numan: UK-headquartered D2C digital health clinic for men's health (erectile dysfunction, hair loss, testosterone) — directly comparable to GoSpring and MySpring in Wellster's portfolio.
- Zava (previously DrEd): European D2C online clinic operating in Germany, UK, France and Ireland providing prescription treatments for sensitive conditions — a directly comparable multi-condition telemedicine platform.
- DoktorABC: German D2C online clinic selling prescription and OTC medications via telemedicine across similar condition verticals (ED, contraception, hair loss, weight loss) — directly competes with Wellster's sub-brands in Germany.
- euroClinix: Pan-European online clinic offering prescription treatments for sensitive indications via telemedicine — a direct peer in the D2C prescription telehealth category.
- 121doc: European D2C online clinic providing prescription treatments across multiple condition verticals — operates the same D2C prescription model as Wellster's sub-brand portfolio.
- Apomeds: German D2C online pharmacy platform integrating prescription-based telemedicine for multiple indications — overlaps with Wellster's prescription + OTC digital clinic model.
Broad incumbents
- Hims & Hers Health: US-listed, large-scale D2C telehealth and consumer health company offering prescription + OTC across men's, women's, dermatology and primary care — same multi-condition D2C clinic archetype as Wellster but at vastly greater scale and US capital markets profile.
- Kry (Livi): Europe's largest general telehealth provider (Sweden-headquartered) operating across multiple EU markets — overlaps with Wellster in the Swedish market and general telemedicine infrastructure, though more focused on synchronous GP consultations.
- Doctolib: Dominant European healthcare booking and telemedicine platform — not a direct condition-specific Rx competitor but increasingly adding telehealth consultation capabilities that could overlap with WellsterMedical's general medicine vertical.
Regional players
- Doktor.se: Sweden's largest D2C telemedicine provider — now directly competes with Wellster's GoLighter in the Swedish market that launched March 2026, making it the most relevant regional incumbent for the new international beachhead.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Wellster Healthtech Group social profiles
Digital presenceWellster Healthtech Group compliance and trust
Trust signalCompliance2 records
Wellster Healthtech Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Wellster Healthtech Group leadership team
Management profileNumber of profiles
Profiles5 records
Wellster Healthtech Group funding detail
Funding detailFunding overview
Funding rounds6 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Wellster Healthtech Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Wellster Healthtech Group
What does Wellster Healthtech Group do?
Wellster Healthtech Group operates a Direct-to-Patient digital health platform providing asynchronous and synchronous telemedicine consultations with German-licensed physicians, integrated prescription fulfillment, and OTC health products across multiple condition-specific sub-brands (men's health, obesity, women's health, hair loss, medical cannabis, self-testing). The ecosystem has served over 2 million patients and is backed by a German-based Medical Advisory Board, Real-World Evidence data infrastructure, and 'Made in Germany' data processing standards.
Is Wellster Healthtech Group a public or private company?
Wellster Healthtech Group is a private company. It is classified as venture growth investor backed and is currently operating.
When was Wellster Healthtech Group founded?
Wellster Healthtech Group was founded in 2018. It employs 51 to 100 people.
Where is Wellster Healthtech Group based?
Wellster Healthtech Group is headquartered in Munich, Germany, in the Europe region.
How does Wellster Healthtech Group make money?
Three revenue lines are on record. Telemedicine Consultations are the primary driver. The others are prescription Medications and OTC Products.
Who are Wellster Healthtech Group's main competitors?
Direct peers on record are Numan, Zava (previously DrEd), DoktorABC, euroClinix, 121doc and Apomeds. Broad incumbents are Hims & Hers Health, Kry (Livi) and Doctolib. Doktor.se is listed as a regional player.
Does Wellster Healthtech Group have an API?
No public API is recorded for Wellster Healthtech Group.
What industry is Wellster Healthtech Group in?
Wellster Healthtech Group's product category is Direct-to-Patient Telemedicine. Its primary akta.pro industry code is HLALAAAD, Prescription-Based Digital Clinics (Condition-Specific Rx Programs), with a secondary code of HLALAGAD, Endocrinology & Diabetes Telemedicine Platforms. Its NAICS code is 6211 and its SIC code is 8011.